SYNAPS Dx is taking this opportunity to raise awareness about the significant progress in accurately diagnosing Alzheimer’s disease (AD). Introducing An Alternative Approach SYNAPS Dx recently presented some exciting new data for the DISCERN™ test at the 2022 Alzheimer’s Association International Conference (AAIC). DISCERN is a diagnostic skin test that assesses the factors directly related to the formation of synaptic connections …
Input your search keywords and press Enter.
Recent Comments